| Literature DB >> 35528995 |
Abstract
FAME III, a multi-centric randomized controlled trial compared fractional flow reserve (FFR) guided percutaneous coronary interventions (PCI) with coronary artery bypass grafting. The study confirmed that compared with FFR-guided-PCI, coronary artery bypass grafting was associated with a significantly lower incidence of the composite of mortality, stroke, MI, and repeat revascularizations at 1 year. Thus, FFR-guided-PCI failed to meet the "noninferiority" criteria. © Indian Association of Cardiovascular-Thoracic Surgeons 2022.Entities:
Keywords: FAME III; FFR-guided-PCI; Fractional flow reserve
Year: 2022 PMID: 35528995 PMCID: PMC9023613 DOI: 10.1007/s12055-022-01346-x
Source DB: PubMed Journal: Indian J Thorac Cardiovasc Surg ISSN: 0970-9134